Deciduous Therapeutics

Deciduous Therapeutics is a biotech company developing novel small molecules that activate the body's endogenous immune surveillance mechanism to selectively eliminate senescent cells. Senescent cells accumulate due to immune surveillance failure and drive inflammation, extracellular matrix remodeling, and metabolic and fibrotic consequences in age-related diseases. By enabling removal of these cells, the company aims to treat multiple classes of age-related diseases and improve health span.